Skip to search formSkip to main contentSkip to account menu

Anti-ICAM-1 Monoclonal Antibody BI-505

Known as: BI-505 
A fully human IgG1 monoclonal antibody directed against intercellular adhesion molecule-1 (ICAM-1 or CD54), with potential antineoplastic activity… 
National Institutes of Health

Related topics

Related topics

1 relation
antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Aspects of Phagocyte Function in Multiple Myeloma
The focus of this thesis was to investigate changes in phenotype and function of myeloid cells in multiple myeloma (MM), that… 
2015
2015
A Phase I Dose-Escalation Study of Antibody BI-505 inRelapsed / RefractoryMultipleMyeloma
Purpose: This multicenter, first-in-human study evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of BI-505… 
2013
2013
A Phase I, Dose Escalation Study of Bi-505 in Relapsed/refractory Multiple Myeloma: P-169
2011
2011
Abstract 4569: Cell death-inducing ICAM-1 antibody has broad and potent anti-myeloma activity in vivo
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL We previously developed combined target and drug… 
2009
2009
B599 Apoptosis-Inducing ICAM-1 Antibody BI-505 Is a Potent Inhibitor of Multiple Myeloma
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)